Programme

Programme subject change as details are confirmed. Current as at 4 September.

Time	Session
8.00am - 5.30pm	Registration open
8.45am - 9.00am	Mihi Whakatau
9.00am - 10.30am	Special Interest Group (SIG) meetings Colorectal Carcinogenesis - view meeting details Melanoma Research and Therapy - view meeting details Supportive Cancer Care - view meeting details
10.30am - 12.00pm	Special Interest Group (SIG) meetings Digital Pathology - view meeting details Gynaecological Cancer League - view meeting details Lung Oncology
12.00pm - 1.00pm	AstraZeneca Lunch Symposium Topic: Advances in the management of early stage EGFR mutated NSCLC Chair: Dr Laird Cameron ADAURA - brief trial summary, Dr Aileen Ludlow ADAURA - discussion, A Prof Chee Lee (virtual) ctDNA applications in early stage NSCLC, Prof Nir Peled Panel discussion including the NZ context: Laird Cameron, Aileen Ludlow, Chee Lee, Nir Peled, Stephen Wong. A light lunch will be provided. Registration is essential
1.00pm - 2.30pm	Special Interest Group (SIG) meetings ctDNA and Plasma Genomics - view meeting details Gastrointestinal - view meeting details Tumour Microenvironment - view meeting details
2.30pm - 3.30pm	Challenges and opportunities for precision oncology and ctDNA analysis for guiding treatment in Aotearoa Inviting researchers and clinicians to come together for a moderated discussion to explore the implementation of precision oncology and ctDNA analysis in NZ. Topics will include the pathway to routine cancer care, and the development of the necessary framework that will need to be implemented to ensure robust clinical delivery.
3.30pm- 5.30pm	Cancer Trials New Zealand CTNZ will host a panel of speakers and a facilitated workshop to discuss the opportunities for creating a national cancer trials network in the context of the planned Aotearoa New Zealand national clinical trials infrastructure. View meeting agenda
5.00pm -7.00pm	Early to Mid Career Networking function Kindly sponsored by Te Aka Mātauranga Matepukupuku

Time	Session
8.30am	Powhiri
9.00am	He Akoranga Whakahoungia Chair: Dr Kimiora Henare Free Software and Collaborative Research Ross Ihaka Cultural safety: a four level paradigm for equity Dr David Tipene-Leach Te Tiriti o Waitangi as a Practice Guide Prof Jacquie Kidd
11.00am	Morning tea
	Tumour microenvironment and clinical trials Chairs: A/Prof Margaret Currie & Dr Elisabeth Phillips	Nursing session
11.30am	Adipose tissue and Obesity : a dangerous duo in breast cancer Prof Catherine Muller-Staumont, Institute of Pharmacology and Structural Biology	Immunotherapy and lung cancer Dr Tony Rahman, Christchurch Hospital
12.00pm	Cancer Trials New Zealand Dr Nicky Lawrence, Te Toka Tumai Auckland
12.20pm	PantoCIN trial results Dr Navin Wewala, Te Pae Hauora o Ruahine o Tararua \| MidCentral
12.30pm	Implementing tikanga Māori into clinical collection streams: 3D Patient-Derived Tumour models for Wāhine Māori in breast and ovarian cancer research Helena Abolins-Thompson, University of Otago, Wellington	TNT in bowel cancer - genetics / mutations Dr Kate Clarke, CCDHB
12.40pm	ACT-NOW: Aotearoa’s first national comprehensive cancer chemotherapy dataset Dr Johanna Paddison, Timaru Hospital, Te Aho O Te Kahu
12.50pm	Treatment patterns and clinical outcomes of neoadjuvant chemotherapy in non-metastatic breast cancer in the Wellington region 2010-2020 Isla Skinner, Wellington Hospital
1.00pm	Lunch Kapa haka
	Precision medicine Chairs: A/Prof Cherie Blenkiron & Dr Tamsin Robb	Nursing session
2.00pm	Analysis of circulating tumour DNA analysis as a liquid biopsy for personalised oncology Dr Stephen Wong, Peter MacCallum Cancer Centre	Nursing – capacity and capability Nadine Gray, Te Aka Whai Ora
2.20pm	Targeting long non-coding RNAs as new therapeutic approach Dr Sarah Diermeier, University of Otago
2.40pm	Precision oncology in Aotearoa: genomic and theranostic platforms in current clinical practice Dr Ben Lawrence, University of Auckland	Breast cancer and Menopause Prof Fran Boyle, University of Sydney and Mater Hospital
3.00pm	Inhibition of innate-immunity enzymes that are hijacked by cancer cells to evolve therapeutic resistance Tracy Hale, Massey University
3.10pm	Patient-derived breast tumour organoids as a NZ-relevant bioresource for research discovery Emma Nolan, University of Auckland
3.20pm	Afternoon tea
	Raising the bar - addressing inequities in cancer care Chair: Dr Paula Barlow & Prof Chris Jackson
3.50pm	Dr Malcolm Mulholland, Massey University Rami Rahal, Te Aho o te Kahu Mel McLeod, Department of Public Health, University of Otago Nadine Gray, Te Aka Whai Ora
5.30 - 7.00pm	Welcome reception amongst the posters Kindly sponsored by Celltrion Healthcare

Time	Session
7.15 - 9.00am	MSD Breakfast symposium Topic: Peri-operative immunotherapy Speakers: A/Prof Alexander van Akkooi, Dr Kate Clarke & Dr Tony Rahman Chair: Dr Annie Wong
	New approaches to old problems Chairs: Dr Laird Cameron & Dr Navin Wewala
9.15am	The promise of neo-adjuvant immunotherapy in melanoma A/Prof Alexander van Akkooi, Melanoma Institute Australia
9.45am	HER-2 Low Invasive Breast Carcinoma: A New Subtype of Breast Carcinoma? Dr Alejandro Contreras, MD Anderson Cancer Centre
10.05am	Presentation of the Bridget Robinson Award
10.10am	Bridget Robinson Award Lecture Helen Morrin, University of Otago, Christchurch
10.40am	Morning tea
11.10am	Pharmac Emerging Researcher Award session Chair: Dr Ben Lawrence
	The effect of Cancer-Associated Fibroblasts on T Cells in colorectal cancer patients using a two-point Immunoscore and multiparameter imaging Rory Costello, University of Otago
	Carboplatin Containing Chemotherapy Compared to Current Standard Neoadjuvant Treatment in Triple-Negative Breast Cancer: A Regional Cancer Service’s Experience Caleb Lucas, Christchurch Hospital
	An Immune Relevant Preclinical Model of Glioblastoma Devlin Forsythe, Victoria University of Wellington
	Pacific peoples’ experiences of cancer and its treatment in Aotearoa: a qualitative study Dr Olivia Perelini, Te Toka Tumai Auckland
	Hyaluronic Acid Biology and its Significance in Pancreatic Ductal Adenocarcinoma Hossein Jahedi, University of Auckland
	Bacterial lipopolysaccharide modulates methylation patterns in colorectal cancer cells Jessica Permain, University of Otago
	Case Series: Outcomes of Immunotherapy in Locally Advanced and Metastatic Cutaneous Squamous cell Carcinoma in Lakes & Waikato Region Ahrabie Yogarajah, Rotorua Hospital
12.40pm	Lunch
	Bruce Cain Memorial Lecture Chair: Dr Richard Isaacs
1.40pm	Introduction to the Bruce Cain Memorial Lecture
1.50pm	Communication skills in medicine: nature or nurture? Prof Fran Boyle, University of Sydney and Mater Hospital
2.30pm	Presentation of the Roche Translational Cancer Research Fellowship
2.40pm	2022 Roche Translational Cancer Research Fellowship recipient presentation Dr Annie Wong, Wellington Blood and Cancer Centre 2019 Roche Translational Cancer Research Fellowship recipient presentation Dr Sharon Pattison, University of Otago
3.30pm	Conference closing
4.00 - 5.00pm	NZSO AGM A/Prof Margaret Currie
6.30pm - midnight	Conference dinner and awards The Ballroom, featuring Crab Farm Kindly sponsored by Imix